RecruitingNCT02039752
Asan Multivessel Registry
Asan Medical Center Registry for Multivessel
Sponsor
Seung-Jung Park
Enrollment
25,000 participants
Start Date
Mar 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.
Eligibility
Min Age: 19 Years
Inclusion Criteria2
- Patients with multivessel disease from 1995 in Asan Medical Center
- Age 19 and more
Exclusion Criteria1
- For prospective cohort, not agreeing to participate with written informed consent form
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERTreatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02039752
Related Trials
TECTONIC CAD IVL IDE Study
NCT0688517741 locations
COronoary Microcirculation Analysis NETwork
NCT074982311 location
CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD
NCT068209701 location
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NCT0719069012 locations
Minimally Invasive Coronary Artery Bypass Supported by Cangrelor
NCT075149621 location